Michael Cannon, a FDA policy expert discusses the impact of FDA's delays in approving contraception on women's economic gains. They explore how FDA regulations create barriers to access and affordability, and the negative impact of FDA's delays on drug approval and prices.
The FDA's delay in approving contraceptives in the 1960s hindered women's entry into the labor force, impacting economic equality.
The FDA's unnecessary prescription requirements for contraceptives impede women's access to necessary medicines and violate healthcare rights.
Deep dives
The Delayed Approval of Contraceptives and Women's Economic Equality
The introduction of reliable contraceptives, such as the pill, allowed women to delay childbearing, pursue education, and spend more time in the workforce. This narrowing of the wage gap between men and women was a significant step towards economic equality. However, the FDA's slow approval process for contraceptives in the 1960s delayed women's entry into the labor force. Even today, the FDA still requires women to get a prescription for the pill, creating barriers to access and affordability, impacting women's economic outcomes and equality with men.
FDA's Regulation and Barrier to Access for Beneficial Medicines
The FDA's regulations and prescription requirements for contraceptives have hindered women's access to necessary medicines and impeded their healthcare rights. Despite the pill being available without a prescription in over 100 countries, the FDA's restrictions continue to control access to contraceptives in the United States. The FDA's power to impose prescription requirements on drugs, even when unnecessary, raises concerns about their misuse and abuse of authority. These unnecessary barriers not only violate healthcare rights but also negatively impact women's health and hinder progress in achieving economic equality.
The FDA's decisions to approve or delay drugs can have major impacts well beyond the health of Americans. Michael Cannon explains how FDA's delays approving contraception impacted women in the labor market.